Market Research Direct Reports Strong Growth in Global Diagnostic Contract Manufacturing Market

The global diagnostic contract manufacturing market is projected to reach USD 44.9 Billion by 2028, according to a new report available from Market Research Direct. This represents a significant increase from the current value of USD 26.0 Billion in 2023, with a CAGR of 11.5% during the forecast period. The market is expected to be driven by the increasing adoption of robotics and automation in manufacturing processes. However, the report also highlights the challenge posed by the growing use of refurbished diagnostic imaging systems.

One of the key findings of the report is the high growth rate of the diagnostic imaging devices segment, which includes CT, X-ray, MRI, Ultrasound, and other imaging devices. This growth is attributed to the rapid economic growth in developing countries, which is expected to drive the adoption of these devices in the coming years.

The report also highlights the orthopedics application segment as the one with the highest CAGR during the forecast period among diagnostic imaging devices. This is due to factors such as the rising geriatric population and the increasing prevalence of orthopedic diseases and disorders.

In terms of region, the Asia Pacific segment is expected to witness the highest growth rate during the forecast period. This is attributed to the low labor costs and rapidly changing healthcare infrastructure in the region, providing ample opportunities for the diagnostic contract manufacturing market.

The report includes insights from supply-side primary interviews with companies of different sizes and designations, as well as from various regions. The prominent companies in the market include Jabil Inc., Flex Ltd., Plexus Corp., Sanmina Corporation, TE Connectivity Ltd., Celestica Inc., Integer Holdings Corporation, Nipro Corporation, Thermo Fisher Scientific, West Pharmaceutical Services Inc., Benchmark Electronics Inc., Kimball Electronics Inc., KMS Systems, Savyon Diagnostics, Nova Biomedical, Cenogenics Corporation, Cone Bioproducts, Avioq, Inc., Philips-Medisize Corporation, Invetech, Meridian Bioscience, Inc., Nolato AB, Fujirebio, Sekisui, Prestige Diagnostics, and Biokit.

The report provides a detailed analysis of the diagnostic contract manufacturing market, categorizing it by device (In Vitro Diagnostic Devices, Diagnostic Imaging Devices, Other Devices), services (Device Development and Manufacturing Services, Quality Management Services, Packaging and Assembly Services, and Other Services), end-user (In Vitro Diagnostic Devices, Diagnostic Imaging Devices, Other Devices), and region (North America, Europe, Asia Pacific, and Rest of the World). It also covers key industry players, their solutions, services, key strategies, contracts, partnerships, and agreements. The report also includes information on new product and service launches, mergers and acquisitions, and recent developments in the market.

The report offers several benefits to stakeholders, including market leaders and new entrants, by providing information on revenue numbers, competitive landscape, and key forecasts.

https://www.marketresearchdirect.com/report/diagnostic-contract-manufacturing-market-by-device-in-vitro-diagnostic-devices-and-diagnostic-imaging-devices-service-device-development-manufacturing-quality-management-and-packaging-assemb/

Coldbath Square, Farringdon
London EC1R 5HL
United Kingdom

Market Research Direct is a dynamic store for market research reports and company profiles, boasting an extensive collection that spans all sectors.

This release was published on openPR.